Response to adjuvant bevacizumab among patients with resected melanoma may vary by age

Bottom Line: Younger patients with resected melanoma had some benefit from adjuvant treatment with the anti-VEGF therapeutic bevacizumab (Avastin) while older patients with resected melanoma did not. Preclinical data showed that VEGF, a protein that promotes angiogenesis and is the target of bevacizumab, decreased with age, and was superseded by the protein sFRP2 in promoting…

Bioplastics no safer than other plastics

Conventional plastic is made from oil. The production of plastic is not sustainable, and it can contain substances we know are dangerous if ingested. In recent years, bioplastics have come onto the market as an alternative to conventional plastic. Bioplastic has some apparent advantages: it is usually made from recycled material or plant cellulose, it…